Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy  Princess U. Ogbogu, MD, Bruce S.

Slides:



Advertisements
Similar presentations
D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Advertisements

Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies  Marija Geroldinger-Simic, MD, Thomas Zelniker,
Risk of an asthma exacerbation after bariatric surgery in adults
Reduced exhaled nitric oxide values in children with asthma after inpatient rehabilitation at high altitude  Johannes Huss-Marp, MD, Ursula Krämer, PhD,
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
Oral immunotherapy–induced gastrointestinal symptoms and peripheral blood eosinophil responses  Michael R. Goldberg, MD, PhD, Arnon Elizur, MD, Liat Nachshon,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults  Peter S. Creticos, MD, Jennifer Maloney,
Stephen J. Fowler, MD, Gaël Tavernier, PhD, Robert Niven, MD 
Alefacept (lymphocyte function-associated molecule 3/IgG fusion protein) treatment for atopic eczema  Dagmar Simon, MD, Jennifer Wittwer, MD, Ganna Kostylina,
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?
A review of treatment with mepolizumab, an anti–IL-5 mAb, in hypereosinophilic syndromes and asthma  William W. Busse, MD, Johannes Ring, MD, PhD, Johannes.
Electron microscopy elucidates eosinophil degranulation patterns in patients with eosinophilic esophagitis  Hedieh Saffari, PhD, Laura H. Hoffman, BSc,
John W. Steinke, PhD, Spencer C. Payne, MD, M
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Allergy testing in predicting outcome of open food challenge to peanut
Does the dermatology standardized letter of recommendation alter applicants' chances of matching into residency?  Rebecca F. Wang, BA, Myron Zhang, MD,
Management of post–liver transplant–associated IgE-mediated food allergy in children  Ghyath Maarof, MD, PhD, Roman Krzysiek, MD, PhD, Jean-Luc Décline,
Nonadherence to Asthma Treatment: Getting Unstuck
Peter M. Wolfgram, MD, David B. Allen, MD 
Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations  Raymond G.
Comparable IgE reactivity to natural and recombinant Api m 1 in cross-reactive carbohydrate determinant–negative patients with bee venom allergy  Thilo.
A. Wesley Burks, MD, Robert A. Wood, MD, Stacie M. Jones, MD, Scott H
Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Atopic dermatitis: A practice parameter update 2012
The Management of Eosinophilic Esophagitis
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Peter Vadas, MD, PhD, Boris Perelman, PhD, Gary Liss, MD, MS 
News Beyond Our Pages Journal of Allergy and Clinical Immunology
What is an “eosinophilic phenotype” of asthma?
Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: A randomized, double-blind clinical trial  Michael Weschta, MD, Dagmar Rimek,
Novel targeted therapies for eosinophilic disorders
Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria  Janine Gericke, PhD, Martin Metz, MD, Tatevik Ohanyan,
Autophagy: Nobel Prize 2016 and allergy and asthma research
News Beyond Our Pages Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Lauren A. DiTommaso, BS, Chen E. Rosenberg, MD, Michael D
Advances in the approach to the patient with food allergy
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome  Florence Roufosse, MD, PhD, Aurore de Lavareille, PhD,
A single intervention for cockroach control reduces cockroach exposure and asthma morbidity in children  Felicia A. Rabito, PhD, MPH, John C. Carlson,
Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years  Mary Lucas, BSc,
Birch pollen–related food allergy: Clinical aspects and the role of allergen-specific IgE and IgG4 antibodies  Marija Geroldinger-Simic, MD, Thomas Zelniker,
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Risk of oral food challenges
Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti–IL-5 antibody SCH55700  Yae-Jean.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Sustained response to mepolizumab in refractory Churg-Strauss syndrome
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens  Riikka Uotila, MD, Anna.
Usa Tantibhaedhyangkul, MD, Carla M. Davis, MD, Lenora M
Contribution of dust mite and cat specific IgE to total IgE: Relevance to asthma prevalence  Elizabeth A. Erwin, MD, Eva Rönmark, PhD, Kristin Wickens,
Macrolide antibiotics and asthma treatment
Asthma: The past, future, environment, and costs
Environmental factors and eosinophilic esophagitis
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Escalating incidence of eosinophilic esophagitis: A 20-year prospective, population- based study in Olten County, Switzerland  Petr Hruz, MD, PhD, Alex.
Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease  Jaclyn Smith, MD, PhD, Emily Owen, MPhil, John Earis, MD,
Natural history of cow’s milk allergy
Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis  David W. Morris, MD, Emily M. Stucke, BA, Lisa.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Advances in mechanisms of allergic disease in 2016
Presentation transcript:

Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy  Princess U. Ogbogu, MD, Bruce S. Bochner, MD, Joseph H. Butterfield, MD, Gerald J. Gleich, MD, Johannes Huss-Marp, MD, Jean Emmanuel Kahn, MD, Kristin M. Leiferman, MD, Thomas B. Nutman, MD, Florian Pfab, MD, Johannes Ring, MD, Marc E. Rothenberg, MD, PhD, Florence Roufosse, MD, Marie-Helene Sajous, MD, Javed Sheikh, MD, Dagmar Simon, MD, Hans-Uwe Simon, MD, PhD, Miguel L. Stein, MD, Andrew Wardlaw, MD, Peter F. Weller, MD, Amy D. Klion, MD  Journal of Allergy and Clinical Immunology  Volume 124, Issue 6, Pages 1319-1325.e3 (December 2009) DOI: 10.1016/j.jaci.2009.09.022 Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Clinical manifestations of HES. The clinical manifestations at initial presentation (A) and at the time of the retrospective analysis (B) are shown as the percentage of patients with evidence of organ involvement referable to a given category. Reported manifestations in each of the categories are listed in this article's Table E1 in the Online Repository at www.jacionline.org. Journal of Allergy and Clinical Immunology 2009 124, 1319-1325.e3DOI: (10.1016/j.jaci.2009.09.022) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Response to treatment. The bars represent response rates after 1 month of therapy (A) and reasons for drug discontinuation (B). Responses were defined as complete (normalization of absolute eosinophil count [AEC] and clinical symptom improvement), partial (reduction of AEC, but not to normal levels, and/or improvement in symptoms), or no response (neither reduction of AEC nor improvement in symptoms). Journal of Allergy and Clinical Immunology 2009 124, 1319-1325.e3DOI: (10.1016/j.jaci.2009.09.022) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Association of serum TARC but not serum IgE levels with prednisone responsiveness. Serum IgE (A) and TARC (B) levels for prednisone responders (n = 129 and 75, respectively) and nonresponders (n = 13 and 8, respectively) are shown by using box-and-whisker plots. The whiskers represent the minimum and maximum values and the horizontal lines represent the lower quartile, median, and upper quartile. Journal of Allergy and Clinical Immunology 2009 124, 1319-1325.e3DOI: (10.1016/j.jaci.2009.09.022) Copyright © 2009 American Academy of Allergy, Asthma & Immunology Terms and Conditions